◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Direxion Daily Healthcare Bull 3X Shares (CURE) ETF Overview

Name: Direxion Daily Healthcare Bull 3X Shares (CURE) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Trading--Leveraged Equity · DATA UPDATED 2026-08-31

Direxion Daily Healthcare Bull 3X Shares (CURE) is an exchange-traded fund managed by Direxion Funds in the "Trading--Leveraged Equity" category. It manages roughly $172 million in assets.

The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.

Interactive chart & fund stats →

CURE Fund Statistics

Expense ratio	0.94%
Trailing yield	1.06%
Assets under management	$172 million
Fund category	Trading--Leveraged Equity
Fund family	Direxion Funds
Inception	2011-06-15

The live price chart, fund profile and news are in the interactive CURE viewer.

Other Companies in Trading--Leveraged Equity

NEBX · Tradr 2X Long NBIS Daily ETF — $191 million
AVL · Direxion Daily AVGO Bull 2X Shares — $190 million
BEX · Tradr 2X Long BE Daily ETF — $174 million
SNDU · T-REX 2X Long SNDK Daily Target ETF — $172 million
NBIL · GraniteShares 2x Long NBIS Daily ETF — $165 million
AXTX · Tradr 2X Long AXTI Daily ETF — $164 million
RKLX · Defiance Daily Target 2X Long RKLB ETF — $164 million
FBL · GraniteShares 2x Long META Daily ETF — $159 million

← CURB All “C” companies CURI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.